Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)
References (16)
- et al.
Cyclophosphamide versus ifosfamide: final report of a randomized phase 11 trial in adult soft tissue sarcoma
Eur J Cancer Clin Oncol
(1987) - et al.
Observations on the use of adjuvant radiation therapy in patients with Stage I and II uterine sarcoma
Int J Radiat Oncol Biol Phys
(1986) - et al.
Cyclophosphamide, vincristine, Adriamycin and dimethyltriazenoimidazolecarboxamide (CYVADIC) for sarcomas of the female genital tract
Gynecol Oncol
(1982) - et al.
Treatment of advanced uterine sarcoma with vincristine, Actinomycin-D, and cyclophosphamide
Gynecol Oncol
(1983) - et al.
Dechloroethylation of ifosfamide and neurotoxicity
Lancet
(1986) - High dose ifosfamide in advanced osteosarcoma and soft tissue sarcoma: preliminary results of two prospective studies....
Design, analysis and interpretation of chemotherapy trials in gynecologic cancer
- et al.
Sarcomas of the uterus: a clinicopathologic study of 119 patients
Obstet Gynecol
(1986)
Cited by (0)
The following are participating institutions and the National Cancer Institute grants supporting this study: University of Alabama at Birmingham (CA 12484), Duke University Medical Center (CA 12534), University of Mississippi Medical Center (CA 13633), University of Miami School of Medicine (CA 37234), The Milton S. Hershey School of Medicine of Pennsylvania State University (CA 16386), Georgetown University Hospital (CA 16938), Indiana University Medical Center (CA 21720), Bowman Gray School of Medicine of Wake Forest University (CA 21946), The Albany Medical College of Union University (unfunded), University of California Medical Center at Irvine (CA 23765), Tufts New England Medical Center (CA 37569), Illinois Cancer Council (CA 27806), Eastern Virginia Medical School (CA 40296), The Johns Hopkins Oncology Center (unfunded), and State University of New York at Stony Brook (unfunded).